Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China.
Junshen HeDonglin LiPing ShenWentong LiangShan KangYi ZhangHongwei ZhaoMubiao LiuXiaohong WangZhong LinXiaonong BinJinghe LangPing LiuChunlin ChenPublished in: International journal of clinical oncology (2021)
In patients with stage FIGO 2018 IIA2 cervical cancer, ARH offers better 5-year OS and DFS outcomes than R-CT; however, due to the inherent biases of retrospective studies, this needs to be confirmed by randomized trials.